Ventilatory Management of the Preterm Neonate in the Delivery Room

Study Overview
=================
Brief Summary
-----------------
The purpose of this study is to evaluate sustained lung inflation followed by early nCPAP as delivery room ventilatory management for preterm neonates at risk of respiratory distress syndrome in reducing their need for mechanical ventilation and ameliorating lung injury without inducing adverse effects compared with intermittent bag and mask ventilation.

Detailed Description
-----------------
Neonatal resuscitation provides lifesaving intervention that, if properly conducted, not only can reduce mortality but probably can significantly decrease subsequent morbidity. Premature infants need appropriate respiratory support and a lung-protective strategy, starting from the delivery room where, on the contrary, an inadequate respiratory approach may influence pulmonary outcome. Mechanical ventilation in the form of positive pressure ventilation has remained the mainstay of treatment of respiratory distress syndrome (RDS) in preterm babies. In recent years, a number of new ventilation strategies have been introduced but the problem of bronchopulmonary dysplasia (BPD) has not been solved. Sustained lung inflation (SLI) lead to a large increase in the tidal volume and the functional residual capacity(FCR) as this intervention may influence the clearance of lung fluids and allow a more even distribution of air throughout the lungs, thus facilitating the formation of FRC. Nasal CPAP and early PEEP act through stabilization and subsequent recruitment of collapsed alveoli, increased FRC resulting in increased alveolar surface area for gas exchange and a decrease in intrapulmonary shunt .also it conserves endogenous surfactant. Previous studies with promising results showed that a combination of sustained lung inflation and early nasal CPAP may be the most effective and least injurious way to recruit the lung in preterm neonates at birth. This study will evaluate sustained lung inflation followed by early nCPAP as delivery room ventilatory management for preterm neonates at risk of respiratory distress syndrome in reducing their need for mechanical ventilation and ameliorating lung injury without inducing adverse effects compared with intermittent bag and mask ventilation.

Official Title
-----------------
Ventilatory Management of the Preterm Neonate in the Delivery Room.

Conditions
-----------------
Respiratory Distress Syndrome, Newborn

Intervention / Treatment
-----------------
* Procedure: Resuscitation of preterm neonates by sustained lung inflation through T piece device followed by CPAP
* Procedure: Resuscitation of preterm neonates by intermittent bag and mask ventilation using self inflating bag.


Participation Criteria
=================
Eligibility Criteria
-----------------
Inclusion Criteria: Preterm infants (gestational age < 34 weeks) Exclusion Criteria: 1. Neonates with major congenital anomalies (congenital heart disease, neural tube defect, trisomy, etc.). 2.Meconium aspiration syndrome, congenital diaphragmatic hernia and anterior abdominal wall defect. 3.Maternal chorioamnionitis. 4.Neonates with gestational age < 26 weeks and /or birth weight less than 750 grams.

Ages Eligible for Study
-----------------
Minimum Age: 27 Weeks
Maximum Age: 33 Weeks

Sexes Eligible for Study
-----------------
All

Accepts Healthy Volunteers
-----------------
No

Study Plan
=================
How is the study designed?
-----------------

Design Details

Primary Purpose: Supportive Care
Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: None (Open Label)


Arms and Interventions

| Participant Group/Arm | Intervention/Treatment |
| --- | --- |
| Active Comparator: Sustained lung inflation followed by CPAP<br>Sustained pressure-controlled inflation using a neonatal mask and a T-piece ventilator (NeoPuff Infant Resuscitator; Fisher & Paykel, Auckland, New Zealand). This will be followed by early CPAP. | Procedure: Resuscitation of preterm neonates by sustained lung inflation through T piece device followed by CPAP<br>* After oropharyngeal and nasal suctioning, if there are no signs of spontaneous breathing or breathing is insufficient and/or heart rate is below 100 bpm, the following approach will be followed:Pressure-controlled (20 cm H2O) inflation will be sustained for 15 secs, using a neonatal mask and a T-piece ventilator (NeoPuff Infant Resuscitator; Fisher & Paykel).To avoid pressure leakage, we will use a neonatal mask of appropriate size which adequately cover both the mouth and nostrils of infants. This pressure controlled inflation will be followed by CPAP at 5 Cm H2O.This procedure will be repeated a second time with a pressure of 25 cm H2O for 15 secs if breathing remained insufficient and/or the heart rate is < 100 bpm and/or the infant is cyanotic. To be followed by CPAP at 6 Cm H2O.A third puff with a pressure of 30 cm H2O for 15 secs will be used after few seconds if inadequate heart rate and respiration was not reached. This will be followed by CPAP at 7 Cm H2O.<br>|
| Active Comparator: Conventional self inflating bag and mask ventilation<br>Intermittent bag and mask ventilation using a self-inflating bag with an oxygen reservoir. | Procedure: Resuscitation of preterm neonates by intermittent bag and mask ventilation using self inflating bag.<br>* After oropharyngeal and nasal suctioning, if there is no signs of spontaneous breathing or breathing is insufficient and/or heart rate is below 100 bpm, intermittent mask and bag ventilation will be administrated at a rate 40-60 per minute using a self-inflating bag and mask with an oxygen reservoir.<br>|

What is the study measuring?
-----------------
Primary Outcome Measures

| Outcome Measure | Measure Description | Time Frame |
| --- | --- | --- |
| Proportionate of neonates in each group who will need endotracheal intubation after failure of positive pressure ventilation through face mask in the delivery room. |  | 2 minutes | 
| Need for mechanical ventilation for neonates on nCPAP |  | 28 days | 

Secondary Outcome Measures

| Outcome Measure | Measure Description | Time Frame |
| --- | --- | --- |
| Occurrence and duration of oxygen therapy. |  | 28 days | 
| Bronchopulmonary dysplasia (BPD): defined as oxygen requirements more than 28 days. |  | 28 days | 
| Pulmonary air leaks |  | 28 days | 
| Patent ductus arteriosus (PDA). |  | 7 days | 
| Necrotizing enterocolitis (NEC). |  | 28 days | 
| Intraventricular hemorrhage (IVH). |  | 28 days | 
| Neonatal sepsis. |  | 28 days | 
| Length of NICU stay. |  | 28 days | 
| Delivery room death or death during admission. |  | 28 days | 
| Inflammatory mediators before and after resuscitation | Serum Interleukin-1β (IL-1β) and Tumor Necrosis Factor-α (TNF-α)will be measured both initial cord blood before any resuscitation is done and a second time two hours after resuscitation. | 2 hours | 

 Terms related to the study
=================
Keywords Provided by Centre Hospitalier Valida
-----------------
Preterm, Neonates, Delivery room, Resuscitation, Ventilation, Neopuff, CPAP